Precision Medicine

The explosion of genetic and molecular medicine has produced mountains of options and evidence. Conversely, there is often an alarming lack of evidence. This is where we come in.

We help you manage the flood of tests and drugs that emerge in this category daily. Accessed through the Hayes Knowledge Center, our comprehensive Precision Medicine solution focuses on thousands of genetic, genomic, and molecular diagnostic tests and precision medicine therapies addressing the questions our clients most frequently ask:

Will testing change patient management for this indication?
If so, what tests and/or therapies should I use?
Should we cover testing and/or therapies?
Can we manage these services internally?

Molecular Test Assessment
Germline Rapid Reports
Precision Medicine Research Briefs

FilmArray Respiratory Panel 2 (BioFire Diagnostics LLC)

Mar 10, 2020 | Molecular Test Assessment

This report evaluates the analytical validity, clinical validity, and clinical utility of the FilmArray Respiratory Panel 2.

Envisia Genomic Classifier (Veracyte)

Mar 5, 2020 | Molecular Test Assessment

This report evaluates the analytical validity, clinical validity, and clinical utility of the Envisia Genomic Classifier.

Pharmacogenetic Testing to Guide Codeine or Tramadol Prescribing for Pain in Pediatric Patients

Feb 19, 2020 | Clinical Utility Evaluation

This report evaluates the clinical utility of pharmacogenetic testing for CYP2D6 gene variants prior to prescribing codeine or tramadol to improve opioid treatment–related outcomes in pediatric patients with organic causes of pain.